RLMD: Relmada Therapeutics Inc

RLMD新闻

• 11:21 Full Transcript: Relmada Therapeutics Q2 2026 Earnings Call
• 21:06 12 Health Care Stocks Moving In Tuesday's After-Market Session
• 18:50 Relmada: 'Hold' Based On Needed NVD-01 Manufacturing Push And Sepranolone Advancement
• 13:30 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
• 13:35 After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD)
• 13:55 Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now
• 13:35 Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround
• 14:47 Relmada: NDV-01 Entering Phase 3 In NMIBC; No Rush To Buy Stock Today (NASDAQ:RLMD)
• 17:38 Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call - Relmada Therapeutics (NASDAQ:RLMD)
• 01:30 Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call Transcript
• 13:55 Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?
• 15:10 Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics
• 14:00 5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
• 19:16 Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)